Soligenix (SNGX) Gross Margin (2010 - 2023)
Soligenix's (SNGX) quarterly Gross Margin came in at 9.5% in Q4 2023, down 5338.0% YoY from 0.18% in Q4 2022, and down 38.01% on a QoQ basis from 15.33% in Q3 2023.
Soligenix (SNGX) Gross Margin (2010 - 2023) Analysis & Trends
Soligenix (SNGX) has 14 years of Gross Margin data on file, last reported at 9.5% in Q4 2023.
- Quarterly Gross Margin fell 5338.0% year-over-year to 9.5% in Q4 2023, while the trailing twelve-month figure through Sep 2024 was 6.39% (down 2528.0% YoY) and the FY2023 annual result came in at 11.59%, down 3036.0% from the prior year.
- Gross Margin eased to 9.5% in Q4 2023, from 15.33% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 62.89% in Q4 2022 to a low of 4.89% in Q2 2021.
- A 5-year average of 21.51% and a median of 15.39% in 2022 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2022 — Gross Margin soared 4839 bps — and 2023, when it plunged 5338 bps.
- Tracing SNGX's Gross Margin over 5 years: stood at 4.95% in 2019, then surged by 124 bps to 11.1% in 2020, then soared by 31 bps to 14.49% in 2021, then surged by 334 bps to 62.89% in 2022, then tumbled by 85 bps to 9.5% in 2023.
- The last three Gross Margin figures came in at 9.5% (Q4 2023), 15.33% (Q3 2023), and 11.07% (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.05 Bn | 131.20 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 78.00 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 65.49 Bn | 60.31 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 56.79 Bn | 51.65 Bn | 52.00 Mn | 35.86% |
| 5 | BeOne Medicines | 42.14 Bn | 37.05 Bn | 1.53 Bn | 89.76% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn | 76.90% |
| 7 | BioNTech SE | 27.71 Bn | 9.32 Bn | 668.28 Mn | 63.27% |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 84.20% |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - | - |
| 10 | Soligenix | 6.21 Mn | 6.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 9.50% |
| Sep 30, 2023 | 15.33% |
| Jun 30, 2023 | 11.07% |
| Mar 31, 2023 | 12.11% |
| Dec 31, 2022 | 62.89% |
| Sep 30, 2022 | 22.09% |
| Jun 30, 2022 | 15.45% |
| Mar 31, 2022 | 50.97% |
| Dec 31, 2021 | 14.49% |
| Sep 30, 2021 | 10.71% |
| Jun 30, 2021 | 4.89% |
| Mar 31, 2021 | 17.10% |
| Dec 31, 2020 | 11.10% |
| Sep 30, 2020 | 36.49% |
| Jun 30, 2020 | 28.09% |
| Mar 31, 2020 | 10.28% |
| Dec 31, 2019 | 4.95% |
| Sep 30, 2019 | 30.57% |
| Jun 30, 2019 | 43.19% |
| Mar 31, 2019 | 18.94% |